Previous 10 | Next 10 |
2023-05-14 12:00:49 ET Leqembi, the new Alzheimer's therapy developed by Biogen ( NASDAQ: BIIB ) and Eisai ( OTCPK:ESALF ) ( OTCPK:ESAIY ), could add $2B - $5B costs to Medicare annually, in the event of broader coverage, according to a recently published study. Early th...
2023-05-11 05:56:21 ET The U.S. Food and Drug Administration (FDA) approved the expanded use of H. Lundbeck ( OTCPK:HLBBF ) ( OTCPK:HLUBF ) and Otsuka's ( OTCPK:OTSKY ) ( OTCPK:OTSKF ) medicine Rexulti (brexpiprazole) to treat agitation associated with dementia due to Alzh...
2023-05-09 09:43:08 ET Anavex Life Sciences Corp. (AVXL) Q2 2023 Earnings Conference Call May 09, 2023, 08:30 AM ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President and Chief Executive Officer Sandra Boenisch - Principal ...
2023-05-09 07:34:51 ET Anavex Life Sciences press release ( NASDAQ: AVXL ): Q2 GAAP EPS of -$0.17 beats by $0.01 . Cash and cash equivalents of $153.5 million at March 31, 2023 compared to $149.2 million at year end September 30, 2022. Newly available preliminary...
Newly available preliminary efficacy results of surrogate biomarkers from the ANAVEX®2-73-AD-004 study; allowing initiation of discussions with regulatory agencies for Accelerated Approval Pathway for ANAVEX®2-73 (blarcamesine) in Alzheimer’s disease with convenient oral treatmen...
2023-05-08 12:26:33 ET Anavex Life Sciences ( NASDAQ: AVXL ) is scheduled to announce Q2 earnings results on Tuesday, May 9th, before market open. The consensus EPS Estimate is -$0.18 (-28.6% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, EPS es...
2023-05-08 11:26:20 ET Major earning expected before the bell on Tuesday include: Cronos Group ( CRON ) Duke Energy ( DUK ) Nikola ( NKLA ) Novavax ( NVAX ) Plug Power ( PLUG ) For further details see: Notable earnings before Tuesday's open
2023-05-04 08:00:00 ET Summary Many treatments for Alzheimer's disease limit the formation of peroxynitrite, which can for a while slow down the progression of the disease. A few treatments for Alzheimer's disease can also scavenge peroxynitrite and reverse some of the damage that...
2023-05-03 15:37:28 ET Eli Lilly ( NYSE: LLY ) added ~7% to reach a new 52-week high Wednesday after the company reported early Phase 3 data for its anti-amyloid agent donanemab in Alzheimer's disease, sparking sharp gains among rival drug developers. Notable gainers include...
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders i...
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...